Early studies focused on the protective effect of recombinant GH and insulin-like growth factor-1 (IGF-1) in cardiomyopathy [70], including ischemic cardiomyopathy, dilated cardiomyopathy (DCM), and tachycardia induced cardiomyopathy. The gene discussed is GH1; the disease is cardiomyopathy.